210 filings
Page 5 of 11
EFFECT
j0fe625qejqyo2i0d
23 Oct 20
Notice of effectiveness
12:15am
CORRESP
0ip6q4qf
20 Oct 20
Correspondence with SEC
12:00am
424B5
5kolqi74c6mvkj5m
8 Oct 20
Prospectus supplement for primary offering
5:26pm
8-K
erys8hbl
8 Oct 20
Entry into a Material Definitive Agreement
5:25pm
UPLOAD
1976qi
24 Sep 20
Letter from SEC
12:00am
8-K
za01b6fl
16 Sep 20
Amendments to Articles of Incorporation or Bylaws
5:27pm
DEFA14A
4av ynra4
19 Aug 20
Additional proxy soliciting materials
12:00am
UPLOAD
a53t8hn
13 Aug 20
Letter from SEC
12:00am
UPLOAD
3uqt7o74hoe x07
10 Aug 20
Letter from SEC
12:00am
CORRESP
7j60gcgu 5k6a6
10 Aug 20
Correspondence with SEC
12:00am
D
qzto9grt1
4 Aug 20
$1.56M in equity / options / securities to be acquired, sold $1.56M, 4 investors
4:08pm
PRE 14A
hqa 7cwx3mmx2oi2
23 Jul 20
Preliminary proxy
9:56pm
8-K
ngswyda
21 Jul 20
Hancock Jaffe Laboratories Announces Pricing of $5.6 Million Offering
5:24pm
424B4
aav89x
20 Jul 20
Prospectus supplement with pricing info
6:31am
EFFECT
9849 h5dvdr
17 Jul 20
Notice of effectiveness
12:15am